A share price of Vicarious Surgical Inc [RBOT] is currently trading at $0.34, up 14.17%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RBOT shares have gain 23.28% over the last week, with a monthly amount drifted -4.23%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 8, April 2024, Vicarious Surgical to Report First Quarter 2024 Financial Results on April 29, 2024. In a post published today on Yahoo Finance, Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the first quarter ended March 31, 2024 after the market closes on Monday, April 29, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
From an analyst’s perspective:
Vicarious Surgical Inc [NYSE: RBOT] stock has seen the most recent analyst activity on March 04, 2022, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $7 from $16. Previously, Credit Suisse started tracking the stock with Outperform rating on January 07, 2022, and set its price target to $16. On December 07, 2021, Cowen initiated with a Outperform rating and assigned a price target of $15 on the stock. Canaccord Genuity started tracking the stock assigning a Buy rating and suggested a price target of $15 on November 05, 2021. BTIG Research initiated its recommendation with a Buy and recommended $15 as its price target on October 18, 2021. Piper Sandler started tracking with a Overweight rating for this stock on October 07, 2021, and assigned it a price target of $16.
Vicarious Surgical Inc experienced fluctuations in its stock price throughout the past year between $0.20 and $2.45. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Vicarious Surgical Inc [NYSE: RBOT] shares were valued at $0.34 at the most recent close of the market. An investor can expect a potential return of 1664.71% based on the average RBOT price forecast.
Analyzing the RBOT fundamentals
Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at -23.38%, Pretax Profit Margin comes in at -20.6%, and Net Profit Margin reading is -22.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.64, Equity is -0.83 and Total Capital is -0.72. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3000 points at the first support level, and at 0.2600 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3600, and for the 2nd resistance point, it is at 0.3800.
Vicarious Surgical Inc [RBOT] reported earnings per share of -$0.06 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.12/share, meaning a difference of $0.06 and a surprise factor of 50.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.1 per share as compared to estimates of -$0.14 per share, a difference of $0.04 representing a surprise of 28.60%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Vicarious Surgical Inc [NYSE:RBOT] is 13.87. As well, the Quick Ratio is 13.87, while the Cash Ratio is 7.26.
Transactions by insiders
Recent insider trading involved Sachs Adam David, CEO, that happened on Mar 20 ’24 when 4830.0 shares were sold. Chief Technology Officer, Khalifa Sammy completed a deal on Mar 20 ’24 to sell 3863.0 shares. Meanwhile, CFO and Treasurer Kelly William John sold 1290.0 shares on Mar 20 ’24.
